✦ LIBER ✦

New developments in glaucoma

✍ Scribed by Murray Fingeret; Kari E. Riina

Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 475 KB
Volume: 9
Category: Article
ISSN: 0953-4431
DOI: 10.1016/s0953-4431(97)10006-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New medical therapies for glaucoma

✍ Siret D. Jaanus 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Primary open angle glaucoma remains the leading cause of blindness world wide. The most recently avatlahle pharmaceutical agents for control of intraocular pressure are the alpha-2 agonist, a topical carbonic anhydraie inhibitor anti a prostaglandin. A brief overview, contrasting these three differe

New glaucoma medications and research, a

New glaucoma medications and research, and a revised paradigm for the treatment and management of glaucoma

✍ Murray Fingeret 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 143 KB

New Developments in Biocatalysis

✍ Chi-Huey Wong 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

New Developments in Biocatalysis

✍ Chi-Huey Wong 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 2 views

New Developments in Drying

✍ Evangelos Tsotsas; Thomas Metzger; Mirko Peglow 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

New developments in immunosuppression

✍ James Neuberger 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Key Points 1. Most liver transplant allograft recipients require long-term immunosuppression, and the most popular therapeutic regimen includes induction therapy, calcineurin inhibitors, corticosteroids, and mycophenolate. 2. Tailoring currently available drugs to the individual may allow bette